World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies in the World as of Jan. 01, 2026

Rank Company Market Cap (USD) Country Sector Industry
361 PureTech Health plc $410.9 M United States US Healthcare US Biotechnology
362 Botanix Pharmaceuticals Limited $409.7 M

(July 1, 2024)

Australia Australian Healthcare Australian Biotechnology
363 Concert Pharmaceuticals, Inc. $401.9 M

(June 1, 2024)

United States US Healthcare US Biotechnology
364 Northwest Biotherapeutics, Inc. $392.7 M United States US Healthcare US Biotechnology
365 iTeos Therapeutics, Inc. $389.6 M

(July 1, 2025)

United States US Healthcare US Biotechnology
366 Medigen Vaccine Biologics Corp $385.1 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
367 Eupraxia Pharmaceuticals Inc. $384.0 M Canada Canadian Healthcare Canadian Biotechnology
368 Cassiopea S.p.A. $383.5 M

(March 1, 2022)

Italy Italian Healthcare Italian Biotechnology
369 Revance Therapeutics, Inc. $381.0 M

(Jan. 1, 2025)

United States US Healthcare US Biotechnology
370 Shandong Sito Bio-technology Co. Ltd $379.7 M China Chinese Healthcare Chinese Biotechnology
371 Cerus Corporation $378.4 M United States US Healthcare US Biotechnology
372 Lineage Cell Therapeutics, Inc. $377.7 M United States US Healthcare US Biotechnology
373 Rocket Pharmaceuticals, Inc. $374.4 M United States US Healthcare US Biotechnology
374 Orchard Therapeutics plc $373.3 M

(Jan. 1, 2024)

United Kingdom UK Healthcare UK Biotechnology
375 Palisade Bio, Inc. $373.0 M United States US Healthcare US Biotechnology
376 Altimmune, Inc. $366.2 M United States US Healthcare US Biotechnology
377 AzurRx BioPharma, Inc. $366.2 M United States US Healthcare US Biotechnology
378 Healios K.K. $357.2 M Japan Japanese Healthcare Japanese Biotechnology
379 Chimerix, Inc. $356.3 M

(Jan. 1, 2025)

United States US Healthcare US Biotechnology
380 Antengene Corp Ltd $354.8 M China Chinese Healthcare Chinese Biotechnology
381 I-Mab $352.8 M China Chinese Healthcare Chinese Biotechnology
382 XOMA Corporation $346.6 M United States US Healthcare US Biotechnology
383 Microbio Co. Ltd $345.5 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
384 Silverback Therapeutics, Inc. $341.8 M

(July 1, 2024)

United States US Healthcare US Biotechnology
385 CytoDyn, Inc. $341.8 M United States US Healthcare US Biotechnology
386 X4 Pharmaceuticals, Inc. $340.1 M United States US Healthcare US Biotechnology
387 AC Immune SA $338.0 M Switzerland Swiss Healthcare Swiss Biotechnology
388 Avacta Group plc $335.6 M United Kingdom UK Healthcare UK Biotechnology
389 Hubei Goto Biopharm Co.,Ltd. $334.2 M China Chinese Healthcare Chinese Biotechnology
390 Gongwin Biopharm Holdings Co. Ltd $332.3 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology

Top Biotechnology Companies in the World as of Jan. 01, 2026

361. PureTech Health plc

Company Profile: PureTech Health plc
Market Cap (USD): $410.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

362. Botanix Pharmaceuticals Limited

Company Profile: Botanix Pharmaceuticals Limited
Market Cap (USD): $409.7 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

363. Concert Pharmaceuticals, Inc.

Company Profile: Concert Pharmaceuticals, Inc.
Market Cap (USD): $401.9 M (June 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

364. Northwest Biotherapeutics, Inc.

Company Profile: Northwest Biotherapeutics, Inc.
Market Cap (USD): $392.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

365. iTeos Therapeutics, Inc.

Company Profile: iTeos Therapeutics, Inc.
Market Cap (USD): $389.6 M (July 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

366. Medigen Vaccine Biologics Corp

Company Profile: Medigen Vaccine Biologics Corp
Market Cap (USD): $385.1 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

367. Eupraxia Pharmaceuticals Inc.

Company Profile: Eupraxia Pharmaceuticals Inc.
Market Cap (USD): $384.0 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Biotechnology

368. Cassiopea S.p.A.

Company Profile: Cassiopea S.p.A.
Market Cap (USD): $383.5 M (March 1, 2022)
Country: Italy
Sector: Italian Healthcare
Industry: Italian Biotechnology

369. Revance Therapeutics, Inc.

Company Profile: Revance Therapeutics, Inc.
Market Cap (USD): $381.0 M (Jan. 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

370. Shandong Sito Bio-technology Co. Ltd

Company Profile: Shandong Sito Bio-technology Co. Ltd
Market Cap (USD): $379.7 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

371. Cerus Corporation

Company Profile: Cerus Corporation
Market Cap (USD): $378.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

372. Lineage Cell Therapeutics, Inc.

Company Profile: Lineage Cell Therapeutics, Inc.
Market Cap (USD): $377.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

373. Rocket Pharmaceuticals, Inc.

Company Profile: Rocket Pharmaceuticals, Inc.
Market Cap (USD): $374.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

374. Orchard Therapeutics plc

Company Profile: Orchard Therapeutics plc
Market Cap (USD): $373.3 M (Jan. 1, 2024)
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

375. Palisade Bio, Inc.

Company Profile: Palisade Bio, Inc.
Market Cap (USD): $373.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

376. Altimmune, Inc.

Company Profile: Altimmune, Inc.
Market Cap (USD): $366.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

377. AzurRx BioPharma, Inc.

Company Profile: AzurRx BioPharma, Inc.
Market Cap (USD): $366.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

378. Healios K.K.

Company Profile: Healios K.K.
Market Cap (USD): $357.2 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

379. Chimerix, Inc.

Company Profile: Chimerix, Inc.
Market Cap (USD): $356.3 M (Jan. 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

380. Antengene Corp Ltd

Company Profile: Antengene Corp Ltd
Market Cap (USD): $354.8 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

381. I-Mab

Company Profile: I-Mab
Market Cap (USD): $352.8 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

382. XOMA Corporation

Company Profile: XOMA Corporation
Market Cap (USD): $346.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

383. Microbio Co. Ltd

Company Profile: Microbio Co. Ltd
Market Cap (USD): $345.5 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

384. Silverback Therapeutics, Inc.

Company Profile: Silverback Therapeutics, Inc.
Market Cap (USD): $341.8 M (July 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

385. CytoDyn, Inc.

Company Profile: CytoDyn, Inc.
Market Cap (USD): $341.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

386. X4 Pharmaceuticals, Inc.

Company Profile: X4 Pharmaceuticals, Inc.
Market Cap (USD): $340.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

387. AC Immune SA

Company Profile: AC Immune SA
Market Cap (USD): $338.0 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

388. Avacta Group plc

Company Profile: Avacta Group plc
Market Cap (USD): $335.6 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

389. Hubei Goto Biopharm Co.,Ltd.

Company Profile: Hubei Goto Biopharm Co.,Ltd.
Market Cap (USD): $334.2 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

390. Gongwin Biopharm Holdings Co. Ltd

Company Profile: Gongwin Biopharm Holdings Co. Ltd
Market Cap (USD): $332.3 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

Stay in touch